[Focal therapy for penile cancer].
BACKGROUND
Focal therapies for superficial penile cancer are today important treatments since organ preservation in penile cancer has a much higher priority than it used to. Because a local recurrence does not substantially influence long-term tumour-specific survival, a slightly higher risk of local recurrence is accepted in favour of maximum organ sparing.


METHODS
Topical chemotherapy and laser ablation can be used for carcinoma in situ, while laser ablation and surgical options are used for Ta/T1 tumours. Radiotherapeutic options can be used, but carry a much higher rate of local complications and lower local control rates.
Urologische Klinik und Poliklinik, Universitätsmedizin Rostock, Schillingallee 35, 18057, Rostock, Deutschland. oliver.hakenberg@med.uni-rostock.de.
O W
OW
Hakenberg
Urologische Klinik und Poliklinik, Universitätsmedizin Rostock, Schillingallee 35, 18057, Rostock, Deutschland.
C
C
Protzel
D000287:Administration, Topical; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001918:Brachytherapy; D006801:Humans; D053685:Laser Therapy; D008297:Male; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D059351:Organ Sparing Treatments / Q000379:methods*; D010412:Penile Neoplasms / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D011878:Radiotherapy
D000970:Antineoplastic Agents
Brachytherapy; Chemotherapy, topical; Neoplasm recurrence, local; Organ preservation; Radiotherapy